课题基金 / 基金详情

Molecular epidemiology of hepatitis E virus in Japan and study on animal host of virus.

Molecular epidemiology of hepatitis E virus in Japan and study on animal host of virus.
日本戊型肝炎病毒分子流行病学及病毒动物宿主研究.
批准号:
16590331
负责人:
ABE Kenji
金额:
$2.3万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

ABE Kenji的其他基金

相似基金

相关文献

中文摘要
翻译
我对来自11个国家的5233份血清中戊型肝炎病毒(HEV)抗体流行率进行了血清流行病学研究,以确定全球范围内戊型肝炎病毒感染的现状。抗hev IgG阳性率分别为:日本东京8.9%、冲绳34.5%、越南河内62.1%、胡志明市41.8%、中国哈尔滨29.2%、泰国27%、缅甸35.1%、尼泊尔66%、美国21.3%、西班牙34%、俄罗斯20.2%、埃及80%、玻利维亚12.7%。在这些受测国家中,抗戊肝病毒IgG的流行率随着年龄的增长而增加,但除日本、美国和西班牙外,大多数参与国16-30岁年龄组的抗体阳性率超过20%。尼泊尔不明原因急性肝炎患者中,56%(14/25)的IgM类抗hev抗体呈阳性。此外,采用巢式PCR检测了3例尼泊尔IgM抗体患者血清中的HEV rna,分离到的HEV基因均为基因型1。我们的研究结果表明,HEV不仅在发展中国家传播,而且在工业化程度更高的国家传播。
英文摘要
I conducted seroepidemiological studies on antibody prevalence to hepatitis E virus (HEV) in 5,233 sera from 11 countries to ascertain the present state of HEV infection on a global basis. The rate of anti-HEV IgG positivity was as follows : 8.9% in Tokyo and 34.5% in Okinawa of Japan, 62.1% in Hanoi and 41.8% in Ho Chi Minh City of Vietnam, 29.2% in Harbin of China, 27% in Thailand, 35.1% in Myanmar, 66% in Nepal, 21.3% in U.S.A., 34% in Spain, 20.2% in Russia, 80% in Egypt and 12.7% in Bolivia, respectively. The prevalence of anti-HEV IgG increased with age in these tested countries, but the rate of antibody positivity was over 20% in the 16-30 year-old group in most of the participating countries, except for Japan, the U.S.A and Spain. Of patients with acute hepatitis of unknown etiology from Nepal, 56% (14/25) were positive for the IgM class of anti-HEV antibody. In addition, HEV RNAs in the serum from 3 Nepali patients who had the IgM antibody were detected by nested PCR and all of the HEV genes isolated belonged to genotype, 1. Our results indicate that HEV is spreading worldwide not only in developing countries, but also in more industrialized countries than previously thought.
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1046/j.1442-200x.2004.01867.x
发表时间: 2004-04-01
期刊: PEDIATRICS INTERNATIONAL
影响因子: 1.4
作者: [Huy, TTT, Abe, K]
通讯作者: Abe, K
DOI: 10.1002/jmv.20175
发表时间: 2004-10-01
期刊: JOURNAL OF MEDICAL VIROLOGY
影响因子: 12.7
作者: [Huy, TTT, Ushijima, H, Abe, K]
通讯作者: Abe, K
DOI: 10.1099/vir.0.19633-0
发表时间: 2004-02-01
期刊: JOURNAL OF GENERAL VIROLOGY
影响因子: 3.8
作者: [Huy, TTT, Ushijima, H, Abe, K]
通讯作者: Abe, K
International collaborative survey on epidemiology of hepatitis E virus in 11 countries.
11个国家戊型肝炎病毒流行病学国际合作调查。
DOI: --
发表时间:
期刊: Southeast Asian Journal of Tropical Medicine and Public Health (印刷中)
影响因子: --
作者: [Kenji Abe, et al.]
通讯作者: et al.
共 11 条
    Comparative pathological study on H5N1 infection between humans and animals
    • 批准号:
      21590449
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      ABE Kenji
    • 依托单位:
    Geographic pathology of HBV-related hepatitis and liver cancers based on characterization of HBV genome variant
    • 批准号:
      21406007
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.23万
    • 财政年份:
      2009
    • 负责人:
      ABE Kenji
    • 依托单位:
    Epidemiological survey of water-borne hepatitis virus infection and study on an improvement in public health
    • 批准号:
      19604004
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2007
    • 负责人:
      ABE Kenji
    • 依托单位:
    The role of cholinergic neurons on the manifestation and retention of experimental neuropathic pain model in mice
    • 批准号:
      19603012
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2007
    • 负责人:
      ABE Kenji
    • 依托单位:
    国内基金
    海外基金
    HEV@BMSC-mito介导M2型巨噬细胞极化促进跨区穿支皮瓣choke血管重塑的机制研究
    • 批准号:
      2026JJ81245
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      黎啸啸
    • 依托单位:
    基于肠肝轴探究肠道菌群代谢产物丁酸调控STAT3乙酰化影响HEV-1感染长爪沙鼠的分子机制
    宽温域环境HEV系统集成优化与能量管理协同控制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      张岩
    • 依托单位:
    基于HEV介导炎症反应与干扰素通路信号交互机制的抗病毒策略研究
    • 批准号:
      82370610
    • 项目类别:
      面上项目
    • 资助金额:
      49万元
    • 批准年份:
      2023
    • 负责人:
      王艺瑾
    • 依托单位: